Ectopic expression of KCNE3 accelerates cardiac repolarization and abbreviates the QT interval

Journal of Clinical Investigation

Volumn 109, Issue 8, 2002, Pages 1083-1090

  Mazhari, Reza ^a,b   Bradley Nuss, H ^a,b   Armoundas, Antonis A ^a,b   Winslow, Raimond L ^b   Marbán, Eduardo ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; PROTEIN KCNE3; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ELECTROCARDIOGRAM; GENE ACTIVATION; GENE EXPRESSION; GUINEA PIG; HEART ARRHYTHMIA; HEART LEFT VENTRICLE; HEART MUSCLE POTENTIAL; HEART REPOLARIZATION; LONG QT SYNDROME; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; QT INTERVAL;

EID: 0036118010     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI0215062     Document Type: Article

References (33)

1. Molecular and cellular mechanisms of cardiac arrhythmias
2. Mechanisms and management of proarrhythmia
3. Spectrum of mutations in long-QT syndrome genes. KVLQT1, HERG, SCN5A, KCNE1, and KCNE2
4. Mutations in the hminK gene cause long QT syndrome and suppress IKs function
5. MiRP1 forms IKr potassium channels with HERG and is associated with cardiac arrhythmia
6. A constitutively open potassium channel formed by KCNQ1 and KCNE3
7. MiRP2, forms potassium channels in skeletal muscle with Kv3.4 and is associated with periodic paralysis
8. The very small-conductance K+ channel KvLQT1 and epithelial function
9. Divergent expression of delayed rectifier K(+) channel subunits during mouse heart development
10. Regulation and properties of KCNQ1 (K(V)LQT1) and impact of the cystic fibrosis transmembrane conductance regulaton
11. Adenovirus-mediated inducible gene expression in vivo by a hybrid ecdysone receptor
12. Distinct gene-specific mechanisms ofarrhythmia revealed by cardiac gene transfer of two long QT disease genes, HERG and KCNE1
13. Construction of adenovirus vectors through Cre-lox recombination
14. Inducible genetic suppression of neuronal excitability
15. Prospects for gene therapy for heart failure
16. Molecular composition of mitochondrial ATP-sensitive potassium channels probed by viral Kir gene transfer
17. Relationship between QaT and RR intervals in rats, guinea pigs, rabbits, and primates
18. Electrophysiological modeling of cardiac ventricular function: From cell to organ
19. Mechanisms of altered excitation-contraction coupling in canine tachycardiainduced heart failure. II. Model studies
20. Ionic bases for electro physiological distinctions among epicardial, midmyocardial, and endocardial myocytes from the free wall of the canine left ventricle
21. I(NaCa) contributes to electrical heterogeneity within the canine ventricle
22. Coassembly of K(V) LQT1 and minK (IsK) proteins to form cardiac I(Ks) potassium channel
23. Two components of cardiac delayed rectifier K+ current. Differential sensitivity to block by class 111 antiarrhythmic agents
24. Characteristics and distribution of M cells in arterially perfused canine left ventricular wedge preparations
25. Cellular basis for the normal T wave and the electrocardiographic manifestations of the long-QT syndrome
26. Enhancement of cardiac function after adenoviral-mediated in vivo intracoronary beta2-adrenergic receptor gene delivery
27. MinK-KvLQT1 fusion proteins, evidence for multiple stoichiometries of the assembled IsK channel
28. A superfamily of small, potassium channel subunits: Form and function of the MinK-related peptides (MiRPs)
29. Structural determinants of KvLQT1 control by the KCNE family of proteins
30. Action potentials, ion channel currents and transverse tubule density in adult rabbit ventricular myocytes maintained for 6 days in cell culture
31. Cultured adult cardiac myocytes: Future applications, culture methods, morphological and electrophysiological properties
32. Modulation ofventricular function through gene transfer in vivo
33. Intracoronary adenovirus-mediated delivery and overexpression of the beta(2)-adrenergic receptor in the heart: Prospects for molecular ventricular assistance